AID  Vol.10 No.4 , September 2020
Hospital Admissions and Mortality in Patients with Rheumatic Heart Disease in Brazil: An Analysis from 2008 to 2018
Abstract: Introduction: The Rheumatic Fever (RF) is a systemic inflammatory disease, caused by Group A beta-hemolytic Streptococcus, predominating in children and adolescents. The clinical manifestations are varied and included in Jones Criteria for diagnosis. The cardiac manifestations are the most relevant, causing severe sequelae such as valvulitis. The RF is still a major public health problem in developing countries despite its primary prophylaxis being simple and effective if well applied. The overall objective of this study was to evaluate the number of hospital admissions and deaths in Brazil from 2008 to 2018. Methodology: Cross-sectional, descriptive, quantitative, documentary study with database provided by the Health Informatics Department of the Brazilian Ministry of Health (DATASUS). Results: In the studied period, a higher prevalence was observed among females (48,232 hospitalizations) and in the adult age group (59,270 hospitalizations and 3972 deaths). The total number of hospitalizations was 83,209 and the total number of deaths was 6572. The total mortality rate was 7.84. The region with the highest number of hospitalizations was the Southeast (22,863 hospitalizations). The total amount spent in hospitalizations was R$879,676,458.63, with an average value per hospitalization of R$ 10,496.21. The average length of stay was 12.7 days. Conclusion: Rheumatic heart disease is an important cause of hospitalizations in Brazil. Measures of early diagnosis and adequate treatment should be strongly stimulated.
Cite this paper: Nunes, M. , Tedde-Filho, G. , Geber-Júnior, J. , Júnior, W. , Peterle, V. and Gomides, A. (2020) Hospital Admissions and Mortality in Patients with Rheumatic Heart Disease in Brazil: An Analysis from 2008 to 2018. Advances in Infectious Diseases, 10, 176-180. doi: 10.4236/aid.2020.104015.

[1]   Burke, R.J. and Chang, C. (2014) Diagnostic Criteria of Acute Rheumatic Fever. Autoimmunity Reviews, 13, 503-507.

[2]   Kumar, R.K. and Tandon, R. (2013) Rheumatic Fever & Rheumatic Heart Disease: The Last 50 Years. The Indian Journal of Medical Research, 137, 643.

[3]   Peixoto, A., Linhares, L., Scherr, P., Xavier, R., Siqueira, S.L., Pacheco et al. (2011) Febre reumática: Revisão sistemática. Revista da Sociedade Brasileira de Clínica Médica, 9, 234-238.

[4]   Roberts, S., Kosanke, S., Dunn, S.T., Jankelow, D., Duran, C.M.G. and Cunningham, M.W. (2001) Pathogenic Mechanisms in Rheumatic Carditis: Focuson Valvular Endothelium. The Journal of Infectious Diseases, 183, 507-511.

[5]   Marijon, E., Ou, P., Celermajer, D.S., Ferreira, B., Mocumbi, A.O., Sidi, D., et al. (2008) Echocardiographic Screening for Rheumatic Heart Disease. Bulletin of the World Health Organization, 86, 81-160.

[6]   Pereira, B.á.F., Belo, A.R. and Silva, N.A. (2017) Rheumatic Fever: Updating Jones criteria in Light of the American Heart Association Review—2015. Revista Brasileira de Reumatologia, 57, 364-368.

[7]   Figueiredo, E.T., Azevedo, L., Rezende, M.L. and Alves, C.G. (2017) Febre Reumática: uma doença sem cor. Arquivos Brasileiros de Cardiologia, 113, 345-354.

[8]   Brazilian Institute of Geography and Statistics (IBGE) (2020) Projection of the Population of Brazil and of the Units of the Federation.

[9]   Belo, W.A., Oselame, G.B. and Neves, E.B. (2016) Perfil clínico-hospitalar de crianças com cardiopatia congênita. Cadernos Saúde Coletiva, 24, 216-220.